THRIVE-CAR-T Digital App
ConditionCAR T-Cell Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPatrick C. Johnson, MD
About this trial
The goal of this clinical trial is to learn if a digital mobile application called THRIVE-CAR-T is helpful for the care of patients undergoing CAR-T cell therapy. The main question\[s\] it aims to answer are whether the THRIVE-CAR-T app is feasible and acceptable to patients.
Eligibility criteria
Qualifiers
Age 18 years or older
Ability to understand English
Diagnosis of a hematologic malignancy
Receiving autologous CAR-T at MGH with an FDA approved cellular therapy product
Disqualifiers
Impaired cognition or uncontrolled mental illness that prohibits the ability to provide informed consent based on the oncology clinician assessment
Already participating in another supportive care clinical trial
Trial design
Treatments tested in this trial
- THRIVE-CAR-T
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Patrick C. Johnson, MD
Lead sponsor
Massachusetts General Hospital
Sponsor institution
Source ClinicalTrials.gov